BRIEF published on 06/26/2026 at 18:05, 2 months 24 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actionnariat Belgique Notification De Transparence Oxurion Opportunités Spéciales Atlas
PRESS RELEASE published on 06/26/2026 at 18:00, 2 months 24 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV erhält eine Transparenzmitteilung gemäß belgischem Recht von Atlas Special Opportunities II LLC bezüglich des Anteilsbesitzes am Unternehmen Technologie Oxurion NV Transparenzmitteilung Belgisches Recht Klinisch Forschung
PRESS RELEASE published on 06/26/2026 at 18:00, 2 months 24 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification regarding shares ownership from Atlas Special Opportunities II, LLC, crossing under the 3% threshold Transparency Notification Euronext Brussels Oxurion NV Shares Ownership Atlas Special Opportunities II LLC
BRIEF published on 06/24/2026 at 18:05, 2 months 26 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Titres Notification De Transparence Oxurion Atlas Special Opportunities II Législation Belge
BRIEF published on 06/24/2026 at 18:05, 2 months 26 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Securities Transparency Notification Oxurion Belgian Legislation Atlas Special Opportunities II
PRESS RELEASE published on 06/24/2026 at 18:00, 2 months 26 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV has received a transparency notification regarding changes in shareholding. The company is focused on technology-enabled clinical research and software platform Clinical Research Transparency Notification Shareholding Software Platform Oxurion NV
PRESS RELEASE published on 06/24/2026 at 18:00, 2 months 26 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC. Oxurion bouwt platform voor klinisch onderzoek en software Transparantiekennisgeving Euronext Brussel Oxurion NV Atlas Special Opportunities II LLC Klinisch Onderzoek
BRIEF published on 06/19/2026 at 15:50, 3 months 2 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actionnariat Plateforme Technologique Notification De Transparence Oxurion Opportunités Spéciales Atlas
BRIEF published on 06/19/2026 at 15:50, 3 months 2 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Technology Platform Atlas Special Opportunities Oxurion
PRESS RELEASE published on 06/19/2026 at 15:45, 3 months 2 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV erhält Transparenzbenachrichtigung gemäß belgischen Vorschriften. Atlas Special Opportunities II LLC informiert über Anteilsverkauf Oxurion NV Belgien Transparenzbenachrichtigung Aktienverkauf Klinischer Forschungsplattform
Published on 09/21/2026 at 15:45, 1 hour 32 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 2 hours 57 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 3 hours 12 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 3 hours 17 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 3 hours 32 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 17:00, 17 minutes ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 16:19, 58 minutes ago clearvise signs new Power Purchase Agreements on favorable terms
Published on 09/21/2026 at 16:11, 1 hour 6 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 09/21/2026 at 16:08, 1 hour 9 minutes ago EQS-Adhoc: EPH Group AG: Purchase agreements signed for the acquisition of an approximately 26,363 m² property in Burgenland
Published on 09/21/2026 at 07:00, 10 hours 17 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
Published on 09/21/2026 at 07:00, 10 hours 17 minutes ago Peugeot Invest entre au capital de Mérieux NutriSciences
Published on 09/18/2026 at 18:34, 2 days 22 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 18:34, 2 days 22 hours ago Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026
